Premenstrual Syndrome: Evidence-based Evaluation and Treatment

@article{Appleton2018PremenstrualSE,
  title={Premenstrual Syndrome: Evidence-based Evaluation and Treatment},
  author={S. M. Appleton},
  journal={Clinical Obstetrics and Gynecology},
  year={2018},
  volume={61},
  pages={52–61}
}
  • S. M. Appleton
  • Published 2018
  • Medicine
  • Clinical Obstetrics and Gynecology
Premenstrual dysphoric disorder (PMDD) is defined by both physical and psychiatric symptoms that impact a woman significantly during the luteal phase of her menstrual cycle. Diagnostic criteria for PMDD were firmly established in the Diagnostic and Statistical Manual of Mental Disorders V in 2013, but many patients fall short of the diagnosis while still appreciably affected by severe premenstrual symptoms. More recent and robust investigations have evaluated the efficacy of treatment ranging… Expand
Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges
TLDR
The management of comorbid PMDD/BD needs as a first step to stabilize the bipolar symptoms by means of optimal dosages of mood stabilizers, and in euthymic BD patients, the PMDD symptoms could be treated with estroprogestins. Expand
Premenstrual syndrome and cortisol
Premenstrual syndrome (PMS), including the severe subtype premenstrual dysphoric disorder (PMDD), DSM-5 category, represents a challenging combination of hormonal, environmental and neuroendocrineExpand
Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder
TLDR
These symptoms are correlated with PMDD symptoms severity and functional impairment, and as such, they should be evaluated, and interventions should be employed in the late luteal phase of women with PM DD. Expand
Internet-Based Cognitive-Behavioural Intervention for Women with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial
TLDR
The iCBT was highly effective in reducing the burden of PMDD, and it appears to be particularly important to address coping styles and stress management in the treatment. Expand
Is Premenstrual Syndrome Associated with Inflammation, Oxidative Stress and Antioxidant Status? A Systematic Review of Case–Control and Cross-Sectional Studies
TLDR
Limited evidence indicates increased levels of inflammatory parameters and suggests decreased antioxidant status in PMS women and to acknowledge the role of inflammation, oxidative stress, and antioxidants status in the pathophysiology of PMS, further research with case–control design and large study groups is needed. Expand
NDT_A_202881 415..426
Gianna Sepede 1 Marcella Brunetti Massimo Di Giannantonio 1,2 1Department of Neuroscience, Imaging, and Clinical Sciences, University “G. d’Annunzio”, Chieti, Italy; 2Department of Mental HealthExpand
Depressive and Anxiety Disorders
TLDR
Key diagnostic criteria and considerations for differential diagnosis for several common depressive and anxiety disorders are introduced and treatment options are explained. Expand
Hypertensive Diseases in Female and Pregnancy
Due to the special physical, psychological, and genetic characteristics of women, especially the different secretion and metabolism of endocrine hormones in their lifetime, the changes of bloodExpand
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population. Despite an array of treatment modalities, depressive disorders remain difficult to manageExpand
Bee products as nutraceuticals to nutraceuticals for bees
TLDR
Bee products have antimicrobial activity and are used in treating Helicobacter pylori, candidiasis, herpes infections, and fungal infections of the skin and genitalia, and are being investigated for its use in autoimmune diseases, especially osteoarthritis. Expand
...
1
2
...

References

SHOWING 1-10 OF 23 REFERENCES
Exercise and premenstrual symptomatology: a comprehensive review.
  • A. Daley
  • Medicine
  • Journal of women's health
  • 2009
TLDR
To make any evidence-based policy recommendations regarding the effectiveness of exercise, more high-quality research is required. Expand
Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder
TLDR
The new antidepressant venlafaxine, which blocks reuptake of serotonin and norepinephrine, seems to be an effective means of treating premenstrual dysphoric disorder. Expand
Efficacy of Depot Leuprolide in Premenstrual Syndrome: Effect of Symptom Severity and Type in a Controlled Trial
TLDR
The differential response to leuprolide suggests that it may possess diagnostic value in determining distinct subtypes of PMS, and women should be evaluated for depression severity before receiving a GnRH agonist. Expand
Selective serotonin reuptake inhibitors for premenstrual syndrome.
TLDR
SSRIs were effective for symptom relief whether taken only in the luteal phase or continuously, with no clear evidence of a difference in effectiveness between these modes of administration. Expand
Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.
TLDR
The beneficial effect of danazol as treatment depends mostly on achieving an an-ovulatory state and elimination of hormonal cyclicity and not on the drug per se. Expand
The premenstrual symptoms screening tool (PSST) for clinicians
TLDR
The PSST applies a necessary degree of measure of severity and impact of premenstrual symptoms, establishes quickly if women qualify for PMDD, and is less time consuming and more practical than two cycles of prospective charting. Expand
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
TLDR
It is demonstrated here that the burden of PMS/PMDD as well as the disability adjusted life years lost due to this repeated-cyclic disorder is in the same magnitude as major recognized disorders. Expand
Intercountry Assessment of the Impact of Severe Premenstrual Disorders on Work and Daily Activities
TLDR
Women suffering from moderate-to-severe PMS/PMDD had increased work absenteeism and work productivity impairment due to premenstrual symptoms relative to those with mild PMS /no perceived symptoms. Expand
Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder
TLDR
This preliminary study suggests that patients with PMDD respond well to treatment with both fluoxetine and AC, however, fluoxettine was more effective for psychological symptoms while the extract diminished the physical symptoms. Expand
Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
TLDR
Calcium supplementation is a simple and effective treatment in premenstrual syndrome, resulting in a major reduction in overall luteal phase symptoms, compared with a 30% reduction in placebo. Expand
...
1
2
3
...